CarGurus, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
/
Date16 Oct 2017
CAMBRIDGE, Mass., Oct. 16, 2017 (GLOBE NEWSWIRE) — CarGurus, Inc. (NASDAQ:CARG), a global, online automotive marketplace connecting buyers and sellers of new and used cars,... Read More →
OrthoPediatrics Corp. Announces Closing of $59.8 Million Initial Public Offering
/
Date16 Oct 2017
WARSAW, Ind., Oct. 16, 2017 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (NASDAQ:KIDS), an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric... Read More →
National Vision Announces Launch of its Initial Public Offering
/
Date16 Oct 2017
DULUTH, Ga., Oct. 16, 2017 (GLOBE NEWSWIRE) — National Vision Holdings, Inc. (“National Vision”) today announced the launch of its initial public offering of 15,800,000... Read More →
Nasdaq Welcomes OrthoPediatrics Corp. (Nasdaq: KIDS) to The Nasdaq Stock Market
/
Date13 Oct 2017
OrthoPediatrics Corp. (Nasdaq: KIDS) Rings The Nasdaq Stock Market Opening Bell in Celebration of Its IPO OrthoPediatrics Corp. (Nasdaq:KIDS) visits the Nasdaq MarketSite in Times... Read More →
Optinose Announces Pricing of Initial Public Offering
/
Date13 Oct 2017
YARDLEY, Pa., Oct. 12, 2017 (GLOBE NEWSWIRE) — OptiNose, Inc. (Optinose), a specialty pharmaceutical company focused on the development and commercialization of products for patients... Read More →
OrthoPediatrics Corp. Announces Pricing of Initial Public Offering
/
Date12 Oct 2017
WARSAW, Ind., Oct. 12, 2017 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics”), an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric... Read More →
CarGurus, Inc. Announces Pricing of Initial Public Offering
/
Date11 Oct 2017
CAMBRIDGE, Mass., Oct. 11, 2017 (GLOBE NEWSWIRE) — CarGurus, Inc., today announced the pricing of its initial public offering of 9,400,000 shares of its Class... Read More →
Rhythm Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
/
Date05 Oct 2017
BOSTON, Oct. 04, 2017 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for treatment of... Read More →
NuCana plc Announces Closing of Initial Public Offering of ADSs and Exercise of Underwriters’ Option to Purchase Additional ADSs
/
Date02 Oct 2017
EDINBURGH, United Kingdom, Oct. 02, 2017 (GLOBE NEWSWIRE) — NuCana plc (Nasdaq:NCNA), a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for cancer patients... Read More →
OrthoPediatrics Corp. Announces Launch of Initial Public Offering
/
Date02 Oct 2017
WARSAW, Ind., Oct. 02, 2017 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics”), an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric... Read More →